T1	Participants 83 195	or intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients
T2	Participants 334 425	partially responding or sensitive relapsed patients with aggressive non-Hodgkin's lymphoma.
